📋 Tender Overview
Many drugs are made by different manufacturers. These products contain the same amount of the active substance and have been tested for safe use. For various reasons policyholders sometimes receive medication from another brand in the pharmacy. Television program De Monitor KRO-NCRV asked a number of important questions about switching medicines and their effect on the control of healthcare costs for health insurers. Read the entire interview with Petra van Holst general director of Health Insurers Netherlands below. The broadcast is on NPO2 on November 9 at 10.15 pm.Do you think there is too much switching of medicinesVan Holst Too much Well patients are complaining about it. That is of course always important. If patients complain about it then something is not going well. One of the things health insurers do is make longer agreements with suppliers namely for two years. That is already an improvement on the policy we originally had. Another advantage is that we ask suppliers for security of supply. This is to avoid having to switch because the supplier says My stock is finished. What I think is important when changing medicines is that the pharmacist is a healthcare provider. This plays an important role in guiding a patient in taking his medicines. How do I do that safely How do I do that sustainably You say therefore communication about the change and the new medicine lies with the pharmacists.Pharmacists have expertise in medicines. And the box goes over the counter at the pharmacist so the pharmacist has an important role to guide the patient in this. Weve talked to pharmacists and who do you think they say who has the main role in communicationYes you may guess that. Maybe they point to the health insurers. But that would of course be very strange because we dont have the expertise. It is not our patient so it would be strange if health insurers had a role in counseling the patient. That is really a specific expertise and belongs to the pharmacist who is a healthcare provider. Can the health insurer not lend a hand to the patient in his complicated search in the policy for what the preferred medications are and when to change themThe health insurer can help with this by communicating more clearly about it. For example by saying Please note if you go to this health insurance company now this and this can mean for your medicines. We are also discussing this with the Patient Federation. Patients also say I do not always receive the medicine for which my doctor prescribes medical necessity. The pharmacist then says the health insurance company does not always reimburse this. We have made agreements about medical necessity. And if the doctor really thinks there is medical necessity that someone really cannot switch then that is also the medicine that the pharmacist can dispense. General practitioners and pharmacists must consult with each other to determine what is best for the patient Thats really important. And it shouldnt be too expensive.Well not too expensive Look as a health insurer we naturally have an important social task to ensure that healthcare remains affordable. That is why we also buy medicines. We have saved billions with this in recent years. And to give you an idea we currently pay around 50 euros less health insurance premiums per year. We find the saving objective or keeping costs manageable as important. And we consider the interests of the insured patient important. We try to make a good decision about this. Do you understand that pharmacists say we are stuck between the doctor and health insurer Because on the one hand they have to follow up on the medical necessity of the doctor and on the other hand they are called on by the health insurer if they spend too many expensive medicines.We will discuss this in order to see what causes it and what we agree with each other. But it is also important that we keep an eye on the costs together. There is a field of tension there that we must constantly discuss with general practitioners pharmacists and patients. What I find important is that there must be good communication between the general practitioner pharmacist and the patient involved. We have now been studying this topic for several weeks. And what is striking is that communication between doctors pharmacists and health insurers is not optimal at all.No we are also working hard to see how we can improve that. And we are strongly in favor of a pharmaceutical consultation in which the healthcare provider because we cannot sit down in his chair looks in the first instance what is happening here and why is that so What can we improve on this You now bring it a bit as if the parties are bickering. But pharmacists say if we too often provide medicines with medical necessity that are not a preferred drug we could be financially cut by the health insurer.We enter into contracts with pharmacists. Agreements are made in this for example about how to deal with changing medicines. And again we always seek the conversation first. And when a discussion is unclear or does not lead to an agreed different policy then in the extreme case there may indeed be financial consequences from the contract. Has the collaboration between pharmacists and health insurance companies not hardened a bitThe collaboration could definitely be improved and I also perceive a hardening. This is precisely a reason to take the initiative and sit down to see how we are going to take the step forward here together.